Cargando…

Essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced NASH model rats

In this study, the fraction extracted from turmeric powder with 50% ethanol and fractionated with n-hexane were administered to diet-induced NASH model rats. NASH model was prepared with SD rats by feeding an originally designed choline-deficient, high-fat, high-fructose (HFF-CD) diet for 10 weeks....

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Yukari, Watanabe, Hitoshi, Kogure, Sarasa, Tanioka, Yuri, Yamauchi, Jun, Furusho, Tadasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676378/
https://www.ncbi.nlm.nih.gov/pubmed/38007567
http://dx.doi.org/10.1038/s41598-023-47097-6
_version_ 1785149928810479616
author Watanabe, Yukari
Watanabe, Hitoshi
Kogure, Sarasa
Tanioka, Yuri
Yamauchi, Jun
Furusho, Tadasu
author_facet Watanabe, Yukari
Watanabe, Hitoshi
Kogure, Sarasa
Tanioka, Yuri
Yamauchi, Jun
Furusho, Tadasu
author_sort Watanabe, Yukari
collection PubMed
description In this study, the fraction extracted from turmeric powder with 50% ethanol and fractionated with n-hexane were administered to diet-induced NASH model rats. NASH model was prepared with SD rats by feeding an originally designed choline-deficient, high-fat, high-fructose (HFF-CD) diet for 10 weeks. To the HFF-CD diet, hexane fraction and 50% ethanol fraction after hexane fractionation were added at 100 mg/kg body weight. 10 weeks later, blood samples and liver were collected for the following parameters: lipid weights, serum ALT, AST, TG, liver TG, TBARS levels, lipid metabolism-related gene expression and histopathological examination of the liver. As the results, the hexane fraction and 50% ethanol fraction showed a decrease in lipid weight, a decrease in hepatic TG, and activation of PPAR-α in the lipid metabolism-related gene test. These results suggest that the hexane fraction of turmeric has an inhibitory effect on fat accumulation in the liver by promoting lipid metabolism in NASH model rats.
format Online
Article
Text
id pubmed-10676378
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106763782023-11-25 Essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced NASH model rats Watanabe, Yukari Watanabe, Hitoshi Kogure, Sarasa Tanioka, Yuri Yamauchi, Jun Furusho, Tadasu Sci Rep Article In this study, the fraction extracted from turmeric powder with 50% ethanol and fractionated with n-hexane were administered to diet-induced NASH model rats. NASH model was prepared with SD rats by feeding an originally designed choline-deficient, high-fat, high-fructose (HFF-CD) diet for 10 weeks. To the HFF-CD diet, hexane fraction and 50% ethanol fraction after hexane fractionation were added at 100 mg/kg body weight. 10 weeks later, blood samples and liver were collected for the following parameters: lipid weights, serum ALT, AST, TG, liver TG, TBARS levels, lipid metabolism-related gene expression and histopathological examination of the liver. As the results, the hexane fraction and 50% ethanol fraction showed a decrease in lipid weight, a decrease in hepatic TG, and activation of PPAR-α in the lipid metabolism-related gene test. These results suggest that the hexane fraction of turmeric has an inhibitory effect on fat accumulation in the liver by promoting lipid metabolism in NASH model rats. Nature Publishing Group UK 2023-11-25 /pmc/articles/PMC10676378/ /pubmed/38007567 http://dx.doi.org/10.1038/s41598-023-47097-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Watanabe, Yukari
Watanabe, Hitoshi
Kogure, Sarasa
Tanioka, Yuri
Yamauchi, Jun
Furusho, Tadasu
Essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced NASH model rats
title Essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced NASH model rats
title_full Essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced NASH model rats
title_fullStr Essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced NASH model rats
title_full_unstemmed Essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced NASH model rats
title_short Essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced NASH model rats
title_sort essential oil components of turmeric inhibit hepatic lipidification and liver fibrosis in a diet-induced nash model rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676378/
https://www.ncbi.nlm.nih.gov/pubmed/38007567
http://dx.doi.org/10.1038/s41598-023-47097-6
work_keys_str_mv AT watanabeyukari essentialoilcomponentsofturmericinhibithepaticlipidificationandliverfibrosisinadietinducednashmodelrats
AT watanabehitoshi essentialoilcomponentsofturmericinhibithepaticlipidificationandliverfibrosisinadietinducednashmodelrats
AT koguresarasa essentialoilcomponentsofturmericinhibithepaticlipidificationandliverfibrosisinadietinducednashmodelrats
AT taniokayuri essentialoilcomponentsofturmericinhibithepaticlipidificationandliverfibrosisinadietinducednashmodelrats
AT yamauchijun essentialoilcomponentsofturmericinhibithepaticlipidificationandliverfibrosisinadietinducednashmodelrats
AT furushotadasu essentialoilcomponentsofturmericinhibithepaticlipidificationandliverfibrosisinadietinducednashmodelrats